PubMed Health⌕ Search

Biomedical subjects

T Balazs

Publications and source records attributed to T Balazs.

At least 55 records · Page 3Linked to original sources

Dehydration and delayed proton equilibria of red blood cells suspended in isosmotic phosphate buffers. Implications for studies of sickled cells.

PO4 buffers isosmotic with plasma or phosphate-buffered saline solution with a substantial proportion of PO4 are often used to wash and suspend red blood cells in studies of respiratory or sickling behavior. Measurements of sequential changes in mean cell hemoglobin concentration, pH, and ion content of red blood cells suspended in 295 mOsm Na-phosphate, pH 7.4, at 23 degrees or 37 degrees C, showed (1) rapid, persistent cell dehydration (mean cell hemoglobin concentration greater than 40 gm/dl) caused initially by Cl- efflux and later by replacement of monovalent Cl- by divalent HPO=4; and (2) temporary reversal of membrane pH gradients with normalization time (30 to 120 minutes) dependent on factors controlling the rate of phosphate-chloride exchange. Sequential equilibration of red blood cells in isosmotic citrate (impermeable) followed by PO4 demonstrated the two stages of the observed shifts in PO4 alone, and red blood cells suspended in 0.15 mol/L 32PO4 at 37 degrees C showed PO4 influx consistent with pH equilibrium kinetics. Sickle trait red blood cells deoxygenated at 37 degrees C, pH 7.4, in plasma or 10 mmol/L HEPES-buffered saline solution showed only 6% to 20% sickling. In isosmotic PO4, mean cell hemoglobin concentration was 40 to 41 gm/dl with approximately 80% sickling. In phosphate-buffered saline solution containing 70 mmol/L PO4, red blood cells showed smaller, similar changes (mean cell hemoglobin concentration approximately 38 gm/dl) with a longer equilibration period and deoxygenated sickle trait cells showed 40% sickling. The altered properties of red blood cells suspended in PO4 or phosphate-buffered saline solution were neither intended nor appropriate for many studies using these media, particularly with hemoglobin S-containing red blood cells, and interpretations of reported results must be reassessed in light of these findings.

Anemia, Sickle Cell↗

Ventricular fibrillation threshold and myocardial cyclic AMP production in rats sensitive or resistant to isoproterenol.

Beta-Adrenoceptor agonists, such as isoproterenol, produce ventricular fibrillation and myocardial necrosis in rats. After the initial insult, a resistance develops to the lesion-inducing effects of subsequent doses of the drug. Cyclic AMP has been considered to play a major role in beta-adrenergic amine-induced myocardial necrosis as well as in the genesis of ventricular fibrillation. In the present studies, we investigated the ventricular fibrillation threshold and the responsiveness of myocardium to cAMP formation in isoproterenol-sensitive and resistant rats. Myocardial necrosis was induced in male Sprague-Dawley rats by subcutaneous injection of isoproterenol at 50 micrograms/kg for 2 consecutive days to make them resistant to subsequent challenges. Control rats received saline. Both groups were challenged 10 days later with graded doses of isoproterenol and ECGs were recorded. In another experiment, hearts from rats similarly treated were used for histopathology and cAMP determinations. The incidence of ventricular fibrillation and death was significantly lower in resistant rats compared with isoproterenol-sensitive rats. All rats pretreated with isoproterenol showed healed myocardial necrosis. The basal myocardial cAMP levels and the levels after in vitro isoproterenol stimulation were not significantly different between isoproterenol- and saline-pretreated rats. Moreover, no significant differences in the responsiveness of myocardium to cAMP formation were noted between the more sensitive apical and less sensitive ventricular regions in resistant or sensitive rats. These data indicate that the altered myocardial sensitivity or the mechanism for the increased ventricular fibrillation threshold in isoproterenol resistance appears to involve factors other than cAMP.

Animals↗

Induction of anti-nuclear antibodies by mercuric chloride in mice.

Mercuric chloride (HgCl2) was administered parenterally to outbred Swiss ICR mice of both sexes and to inbred A/J male mice. In repeated experiments both male and female ICR mice developed anti-nuclear antibodies (ANA) giving a distinctive nucleolar fluorescence pattern in response to HgCl2 treatment. Within 1 week after the start of treatment, many of the mice had serum ANA of the IgG class directed against nucleolar antigen(s). Maximum ANA induction was reached by week 4. Inbred A/J male mice were resistant to the induction of ANA by HgCl2.

Animals↗

Radioimmunoassay of conjugated bile acids in canine and feline sera.

A solid-phase radioimmunoassay for the measurement of total conjugated bile acids was validated for use in dogs and cats. The method used an 125I-labeled iodoglycocholate tracer and polypropylene assay tubes coated with rabbit antiserum against the major conjugated bile acids. Standard solutions of sodium taurocholate provided with the kit and serial dilutions of canine and feline sera containing low, medium, and high endogenous bile acid concentrations inhibited binding of the [125I]iodoglycocholate tracer to the antibody in a parallel manner; this inhibition indicated specificity of the assay for bile acids in the serum of dogs and cats. Increased serum bile acid concentrations in animals with liver disease confirmed the biologic specificity of the assay in dogs and cats. Accuracy was shown by quantitative recovery of purified sodium taurocholate from canine and feline sera. Intra-assay precision was 7.2% to 17.3% for dogs and 8.5% to 18.5% for cats. Interassay precision was 4.8% to 17.2% for dogs and 3.5% to 11.2% for cats. The sensitivity of the assay in dogs and cats was 0.4 mumol/L. Solid-phase radioimmunoassay is a valid method for the direct measurement of total conjugated bile acids in the dog and cat, and is of value in the diagnosis of hepatobiliary disease in these species.

Animals↗

Further studies on 6-mercaptopurine-induced muscle atrophy in rats, mice, and hamsters treated as neonates.

In previous studies, we found that Sprague-Dawley rats injected with 6-mercaptopurine monohydrate (6-MP) at 2 mg base/kg sc daily from 2 to 22 days of age had atrophy of thigh and sublumbar muscles when killed at 16 months of age. The first sign of this muscle atrophy was detected grossly (flattened croup with or without paresis) at 12 months of age. In one experiment of the present work, using the same treatment in rats as above, we found that the earliest onset of muscle atrophy observed by light microscopy occurred at 2 months of age. By 4 months the atrophy could be detected grossly. The atrophy did not uniformly involve all muscles of the hindquarters; the thigh (especially the semitendinosus), leg (soleus but not the extensor carpi group), and lumbar vertebral (including the psoas) muscles were involved. Foreleg (biceps), intercostal, and tongue muscles as well as the sciatic nerve and internal organs appeared unaffected. In another experiment, weanling Sprague-Dawley rats given large daily doses of 6-MP from 25 to 45 days of age had normal muscles when killed at 8 months. In a third experiment, Wistar rats injected with 6-MP (2 mg base/kg sc) daily from 2 to 22 days of age and killed at 6 months had muscle atrophy similar to that seen in Sprague-Dawley rats. In the last experiment, mice and hamsters given large daily doses of 6-MP from 2 to 22 days of age had normal muscles when killed at 10 months. It appears from these results that the 6-MP-induced muscle atrophy occurs only after treatment during the neonatal period and that the atrophy may be species specific.

Animals↗

Determinants of resistance to the cardiotoxicity of isoproterenol in rats.

Induction of myocardial necrosis by isoproterenol produces resistance to the necrogenic effects of subsequent doses of the drug. A series of experiments were performed to further define the determinants of resistance. Myocardial necrosis was induced in male Sprague-Dawley rats by sc injection of isoproterenol at 50 micrograms/kg daily for 10 consecutive days or as a single dose at 50, 5, or 0.5 micrograms/kg. These preconditioning doses were followed, at various times, by a challenge dose of 50 micrograms/kg. The rats were killed 48 hr after the challenge dose, and their hearts were analyzed morphometrically to determine the amount of acute necrosis and scarring. The amount of scar tissue was a reflection of necrosis caused by the preconditioning dose whereas acute necrosis reflected response to the challenge dose. Resistance occurred and lasted longer than 19 to 20 weeks after both single or multiple isoproterenol injections of 50 micrograms/kg, but it was not observed 5 days after administration of a single preconditioning dose. Isoproterenol at 0.5 micrograms/kg produced only very minimal or no myocardial necrosis and did not produce resistance. The resistance was not dependent on the size of the area of necrosis produced during the preconditioning period, showing that it was not due to destruction of all vulnerable muscle by the preconditioning dose(s). The preexistence of lesions, however, was necessary for the development of resistance. It is concluded that development of resistance to the necrogenic effects of isoproterenol reflects an adaptive alteration in the myocardium which survives after a necrogenic dose.

Animals↗

Procainamide-induced antinuclear antibodies in beagle dogs.

Procainamide produces a high incidence of autoimmune reactions in humans. To establish an animal model, we treated three groups of beagle dogs with increasing doses of procainamide HCl (100 to 200 mg/kg) for 11 to 14 months. Sera were examined before and during treatment for antinuclear antibodies (ANA) at a 1:10 dilution by an indirect immunofluorescence assay. The first group of six dogs, which were 1 year old and born in our colony, remained generally negative for ANA. In the second group of four dogs, which were of the same origin but were 3 to 6 years old, two developed ANA after 4 months of treatment. The third group of four dogs were 3 to 6 years old and had been born in the FDA colony to parents originating from another source. These dogs developed ANA after 1 to 2 months and remained generally positive throughout the 11 months of treatment. Dogs of the control groups remained negative except for one that was ANA-positive on several occasions. Three of the ANA-positive treated dogs and the ANA-positive control dog had circulating immune complexes. Serum procainamide concentrations were comparable in dogs of each group; acetylprocainamide was not detected. No alterations were found in serum proteins or in the hemograms, and no clinical signs were seen. The data suggest that age plays a contributory role in the development of this autoimmune response in the dog.

Aging↗

Age-dependent changes in electrophysiologic characteristics of fast and slow action potentials in rat papillary muscle.

Isolated papillary muscles from juvenile (about 2 months old, average weight of 250 g) and young adult rats (about 4 months old, average weight 485 g) were studied for age-dependent differences in the characteristics of fast and slow action potentials (APs). The fast and slow APs were recorded in 5.4 mM and 25 mM K+-Tyrode solutions, respectively (stimulation rate of 1 Hz). For the slow APs, the dose-response curves for isoproterenol versus Vmax (the maximum rate of rise of the APs), overshoot, and AP amplitude were linear between 10(-9) M and 10(-6) M (10(-5 M in some cases) in the juvenile and young adult rats. Isoproterenol pretreatment (1 mg/kg s.c., 1 h prior) decreased the slope of the dose-response curve, and saturation was achieved at a lower concentration. The Vmax, overshoot, and amplitude of both the fast and slow APs were somewhat smaller in the young adult rats than in the juvenile rats; there were no differences in the resting potential, AP duration, or threshold voltage. These results suggest that activation of a greater fraction of the beta-adrenergic receptors is coupled directly or indirectly to activation of a greater fraction of the slow channels. The pretreatment data suggest that down-regulation of the beta-adrenergic receptor may occur. The conductance per channel for the fast Na+ channels and slow channels, and (or) the number of both types of functional channels, may decrease with age.

Action Potentials↗

Reversal of propranolol and verapamil toxicity by calcium.

Because of the increasing use of propranolol and verapamil in combination, a study of their interaction was conducted. In rabbits, propranolol given IV at 1 mg/kg followed by an IV infusion of verapamil at 0.1 mg/kg/min for 15 min caused profound hypotension, bradycardia, A-V block, and death in less than 1 h in each of 30 animals. In rabbits treated with propranolol and verapamil as above, calcium chloride (300 mg/kg) given IV immediately after verapamil infusion restored blood pressure and cardiac conduction to normal but the heart rate remained slow; all 12 animals survived. In miniature swine under sodium pentobarbital anesthesia, propranolol (0.5 mg/kg) and verapamil (0.5 mg/kg) IV produced the same physiological changes and death within 15 min in each of eight animals. Calcium chloride given at 150 mg/kg to miniature swine after propranolol and verapamil injections prevented death of each of the five animals; blood pressure and the electrocardiogram were restored to normal, although bradycardia persisted. In mice, the IP LD50 value of propranolol HCl, which is 80 +/- 2.7 mg/kg, was decreased to 10 mg/kg when the drug was given in combination with verapamil HCl at an IP dose of 3 mg/kg, which is less than 1/10 of its LD50. Deaths occurred within minutes and were preceded by convulsions. Pretreatment of mice with calcium chloride (600 mg/kg, IV) prevented death due to the combination of propranolol and verapamil. The data indicate that verapamil enhances the toxicity of propranolol and that calcium can antagonize this effect.

Animals↗

Drug-induced antinuclear antibodies in the guinea pig.

Antinuclear antibodies (ANA) development was studied in male guinea pigs in response to chronic treatment with procainamide, hydralazine, acetanilide or caffeine. Acetanilide and caffeine have not previously been associated with ANA induction. Fifty-one weanling Hartley guinea pigs were divided into five groups which received either procainamide, hydralazine, acetanilide, caffeine or saline sc for 55 weeks; drug dosage was 10 mg/kg initially and was increased incrementally to 40 mg/kg by 10 months except for hydralazine, which was increased to 20 mg/kg. Two weeks before initiation of treatment, 1 mg of the appropriate drug in 0.4 ml of buffered Freund's complete adjuvant (FCA-PBS) was administered intradermally. Controls received FCA-PBS only. Sera ANA were assayed at 6, 10 and 13 months. After 13 months of treatment, those sera which were ANA positive were assayed for anti-deoxyribonucleoprotein antibodies and were titered for ANA. Chi-square analyses were performed on results of the 10- and 13-month ANA screening results. ANA induction was significant at P = 0.05 only for the group receiving procainamide at both 10 and 13 months of treatment. When the cumulative results of all ANA screens were analyzed, ANA induction was significant for procainamide, acetanilide and caffeine. The test system did not prove to be promising for unambiguous identification of drugs with ANA-inducing potential, but may be useful for studies of mechanisms of ANA induction by chemicals.

Acetanilides↗

Effects of endotoxin tolerance on hepatic excretory function: in vivo study.

Induction of endotoxin tolerance in rats led to reductions in bile flow and BSP excretion. BSP serum retention or storage of BSP in the liver was not affected. Although serum alanine aminotransferase (ALT) activity was slightly elevated in endotoxin-tolerant rats, the levels of serum aspartate amino-transferase (AST) and hepatic 5'-nucleotidase were normal. These in vivo data support the validity of in vitro studies demonstrating the cholestatic effect of endotoxin and the viewpoint that endotoxin may be responsible for the cholestatic jaundice associated with Gram-negative bacterial infections.

Animals↗

Protective effects of clonidine and verapamil in experimental amitriptyline poisoning in rabbits.

The effects of various agents on acute amitriptyline-induced cardiotoxicity were investigated in conscious rabbits. Amitriptyline (50 mg/kg, IP) regularly produced consistent and reproducible electrocardiographic changes such as lengthening of Q-T intervals, widening of the QRS complex, arrhythmias of various types, convulsion, and severe hypotension. Prevention of these toxic manifestations by the use of various agents alone or in combination was explored. Clonidine (50 micrograms/kg, IV) and verapamil (0.25 mg/kg, IV) alone or in combination at lower doses (25 micrograms/kg plus 0.125 mg/kg, respectively) significantly reduced the lengthening of the QRS and Q-T intervals, restored sinus rhythm, maintained blood pressure at a constant level, and protected against a lethal dose of amitriptyline (75 mg/kg). These results suggest that verapamil, clonidine, and their combination appear to be promising antidotal agents in restoring cardiac function under these conditions.

Amitriptyline↗

Alteration of high-affinity binding sites of neurotransmitter receptors in rats after neonatal exposure to streptomycin.

Central neurotransmitter functions were analyzed in dyskinetic rats that were treated subacutely with streptomycin as neonates. Data indicated that the treatment caused an increase in the binding of [3H]spiroperidol in striatum and of [3H]serotonin in frontal cortex, but no significant changes were observed in the binding of [3H]quinuclidinyl benzilate and [3H]muscimol to cerebellum and of [3H]diazepam to frontal cortex. The increase in the binding of [3H]spiroperidol and [3H]serotonin was evident in both sexes; however, the increase of [3H]spiroperidol binding was statistically significant only in females. Kinetic studies as revealed by Scatchard plots show that the increase in the binding of the two ligands is due to an increase in the number of the receptors. These results support the concept of a central mechanism of action for the streptomycin-induced dyskinesias.

Animals↗

Effect of a low-protein diet on contraceptive steroid-induced cholestasis in rats.

Female Sprague-Dawley rats were given daily oral doses of 2 combined oral contraceptive (OC) steroids, 17 alpha-ethinyl estradiol (EE2) and 19-norethisterone (NE), for a maximum of 8 weeks. A low-dose group of rats received 0.25 mg/kg EE2 and 2.50 mg/kg NE. A high-dose group was given weekly doubled doses until levels of 4 mg/kg EE2 and 40 mg/kg NE were reached. The rats were fed a low-protein (LP) (8%) diet starting 8 weeks before treatment with the OC and continuing throughout the study. Cholestatic liver injury, as measured by basal bile flow, bile acid secretion, and organic anion (bromosulfophthalein) excretion, could be induced in control rats receiving the LP diet alone. In control animals on a normal diet, steroid administration alone produced a marked dose-dependent cholestatic effect. However, the combination of a chronic LP diet with OC resulted in an ameliorating effect on the pathophysiology of bile secretion and hepatic excretory function. The histopathological adaptive changes induced by OC were absent when the LP diet was administered simultaneously. Thus, in the rat, mild protein malnutrition does not enhance the cholestatic effect of the steroids but rather protects the liver from cholestatic liver damage caused by an LP diet or OC administration alone.

Animals↗